{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-059479","form_type":"8-K","ticker":"HRTX","cik":"0000818033","company_name":"HERON THERAPEUTICS, INC. /DE/","filed_at":"2025-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.386326+00:00","generated_at":"2026-05-23T04:28:09.720476+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Heron Therapeutics appoints Mark Hensley as COO effective April 28, 2025","bullets":["Annual base salary of $553,000; target cash bonus of $276,500 (50% of base), prorated for 2025.","Inducement awards: option for 500K shares, 500K RSUs, and performance option for up to 900K shares.","Vesting: option and RSUs vest over 4 years; performance option vests upon stock price goals.","Hensley previously served as CEO of Veloxis Pharmaceuticals from 2021 to 2024.","Awards granted outside 2007 Plan as material inducement under Nasdaq Rule 5635(c)(4)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-059479","json":"https://secwatch.observer/filing/0000950170-25-059479.json","markdown":"https://secwatch.observer/filing/0000950170-25-059479.md","text":"https://secwatch.observer/filing/0000950170-25-059479.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818033/000095017025059479/0000950170-25-059479-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818033/000095017025059479/hrtx-20250428.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T04:28:09.720476+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"788f96d319","claim":"Mark Hensley was appointed as Chief Operating Officer at HERON THERAPEUTICS, INC. /DE/.","evidence_excerpt":"On April 28, 2025, Heron Therapeutics, Inc. (the “ Company ”) announced that it appointed Mark Hensley as Chief Operating Officer, effective April 28, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025059479/0000950170-25-059479-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}